Lupin · The Institute of Chartered Accountants of India
Chartered Accountant and FP&A leader co‑heading the Biosimilars BU, manufacturing plant, and R&D. I drive P&L ownership, driver‑based forecasting, and finance‑led operational improvements while building automation and analytics to speed decision making. Open to connections on business finance, manufacturing economics, and finance transformation.
Progressing to Manager, co‑heading FP&A for the Biosimilars SBU, plant, and R&D portfolio. In this role, I lead budgeting, forecasting and enable enterprise decision-making through advanced financial analysis, business performance tracking, scenario planning, and cross-functional collaboration, driving sustainable growth and operational excellence. My focus is on translating operational metrics into strategic insights that support timely executive decisions and long‑term growth.
Entered the world of Business Finance for Biosimilars, supporting monthly P&L closing, plant OPEX, and R&D with clear variance commentary for senior reviews. Delivered ad hoc projects including rapid business cases, board decks, SKU profitability reviews, and alliance analyses. Gained cross‑functional exposure to business development, program management, supply chain, regulatory affairs, and biosimilars manufacturing.
Gained comprehensive, cross-functional experience in Audit & Assurance, Direct Taxation, and Corporate Law compliance. Serviced a diverse portfolio of clients, including publicly listed and privately held companies across various. Handled various corporate law assignments, including statutory filings with the Ministry of Corporate Affairs (MCA) and ensuring compliance under the Companies Act, 2013